Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;83:635-644

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomita, M.
Right arrow Articles by Zile, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomita, M.
Right arrow Articles by Zile, M. R.

Circulation, Vol 83, 635-644, Copyright © 1991 by American Heart Association


ARTICLES

Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function

M Tomita, FG Spinale, FA Crawford and MR Zile
Department of Medicine, Cardiology Division, F.A.C., Medical University of South Carolina, Charleston 29425.

Chronic supraventricular tachycardia causes a dilated cardiomyopathy in man. Terminating this tachycardia appears to result in symptomatic improvement; however, its effects on left ventricular (LV) volume, mass, and function have not been fully examined. Accordingly, hemodynamic studies using simultaneous echocardiography and catheterization were performed in three groups of pigs: 1) those subjected to rapid left atrial pacing (240 beats/min) for 3 weeks (SVT, n = 8), 2) those subjected to supraventricular tachycardia for 3 weeks followed by termination of pacing and a 4-week recovery period (PSVT, n = 9), and 3) sham-operated controls (CTR, n = 10). Systolic pump function was assessed using fractional shortening (FS), peak ejection rate [peak (-)dD/dt], and maximum rate of pressure development [peak (+)dP/dt]. Diastolic function was assessed using the time constant of isovolumic pressure decline (tau), peak early diastolic filling rate [peak (+)dD/dt], the chamber stiffness constant (Kc), and the myocardial stiffness constant (Km). Supraventricular tachycardia caused LV dilation (end-diastolic dimension [EDD] increased from 3.5 +/- 0.4 cm in CTR to 4.9 +/- 0.5 cm in SVT, p less than 0.05) but no change in LV mass (LV weight-to-body weight ratio [LV/BW]) was 2.58 +/- 0.3 g/kg in CTR and 2.66 +/- 0.4 g/kg in SVT), all indexes of systolic function became abnormal (FS fell from 30 +/- 4% in CTR to 13 +/- 5% in SVT, p less than 0.05), and the indexes of relaxation and filling were slowed (tau increased from 36 +/- 3 msec in CTR to 51 +/- 13 msec in SVT, p less than 0.05). There were no significant changes in Kc or Km. After terminating the supraventricular tachycardia, LV volume fell but remained greater than that in CTR (EDD was 4.2 +/- 0.4 cm in PSVT, p less than 0.05 versus CTR) and substantial LV hypertrophy developed (LV/BW was 3.48 +/- 0.5 g/kg in PSVT, p less than 0.05 versus CTR). Systolic function returned to normal (FS was 31 +/- 5% in PSVT) but diastolic function remained abnormal. In PSVT, tau remained prolonged (49 +/- 12 msec, p less than 0.05 versus CTR), Kc increased from 3.7 +/- 1.0 in CTR to 7.4 +/- 1.2 (p less than 0.05), and Km increased from 4.4 +/- 1.5 in CTR to 13.9 +/- 9.7 (p less than 0.05). Thus, the improvement in systolic function that occurs after the termination of supraventricular tachycardia is associated with the development of LV hypertrophy and persistent diastolic dysfunction.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Tachibana, H.-J. Cheng, T. Ukai, A. Igawa, Z.-S. Zhang, W. C. Little, and C.-P. Cheng
Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H914 - H922.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K.-L. He, M. Dickstein, H. N. Sabbah, G.-H. Yi, A. Gu, M. Maurer, C.-M. Wei, J. Wang, and D. Burkhoff
Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization
Cardiovasc Res, October 1, 2004; 64(1): 72 - 83.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. M. Yarbrough, R. Mukherjee, G. P. Escobar, J. W. Hendrick, J. A. Sample, K. B. Dowdy, J. E. McLean, J. T. Mingoia, F. A. Crawford Jr, and F. G. Spinale
Modulation of calcium transport improves myocardial contractility and enzyme profiles after prolonged ischemia-reperfusion
Ann. Thorac. Surg., December 1, 2003; 76(6): 2054 - 2061.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. J. Pilla, A. S. Blom, D. J. Brockman, V. A. Ferrari, Q. Yuan, and M. A. Acker
Passive ventricular constraint to improve left ventricular function and mechanics in an ovine model of heart failure secondary to acute myocardial infarction
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1467 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. K. King, M. L. Coker, A. Goldberg, J. H. McElmurray III, H. R. Gunasinghe, R. Mukherjee, M. R. Zile, T. P. O'Neill, and F. G. Spinale
Selective Matrix Metalloproteinase Inhibition With Developing Heart Failure: Effects on Left Ventricular Function and Structure
Circ. Res., February 7, 2003; 92(2): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Stroud, C. F. Baicu, M. A. Barnes, F. G. Spinale, and M. R. Zile
Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2324 - H2335.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H J Muntinga, F van den Berg, M G Niemeyer, P K Blanksma, E E van der Wall, and H J G M Crijns
Left ventricular diastolic function after electrical cardioversion of atrial fibrillation
Heart, April 1, 2002; 87(4): 379 - 380.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. S. Bradham, G. Moe, K. A. Wendt, A. A. Scott, A. Konig, M. Romanova, G. Naik, and F. G. Spinale
TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1288 - H1295.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Takagaki, P. M. McCarthy, T. Tabata, R. Dessoffy, L. A. Cardon, J. Connor, Y. Ochiai, J. D. Thomas, G. S. Francis, J. B. Young, et al.
Induction and maintenance of an experimental model of severe cardiomyopathy with a novel protocol of rapid ventricular pacing
J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 544 - 549.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. LOPEZ BERGAMI, J. SCAGLIONE, and M. J. LEVIN
Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic
FASEB J, December 1, 2001; 15(14): 2602 - 2612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. A. Modesti, S. Vanni, I. Bertolozzi, I. Cecioni, G. Polidori, R. Paniccia, B. Bandinelli, A. Perna, P. Liguori, M. Boddi, et al.
Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H976 - H985.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Clair, M. K. King, A. T. Goldberg, J. W. Hendrick, R. Nisato, D. M. Gay, A. E. Morrison, J. H. McElmurray III, R. S. Krombach, B. R. Bond, et al.
Selective Vasopressin, Angiotensin II, or Dual Receptor Blockade with Developing Congestive Heart Failure
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 852 - 860.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
F. G Spinale, M. L Coker, B. R Bond, and J. L Zellner
Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target
Cardiovasc Res, May 1, 2000; 46(2): 225 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. J. Patel, J. J. Pilla, D. J. Polidori, S. V. Pusca, T. A. Plappert, M. S. J. Sutton, E. B. Lankford, and M. A. Acker
TEN WEEKS OF RAPID VENTRICULAR PACING CREATES A LONG-TERM MODEL OF LEFT VENTRICULAR DYSFUNCTION
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 834 - 841.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. V. Houck, L. C. Pan, S. B. Kribbs, M. J. Clair, G. M. McDaniel, R. S. Krombach, W. M. Merritt, C. Pirie, J. P. Iannini, R. Mukherjee, et al.
Effects of Growth Hormone Supplementation on Left Ventricular Morphology and Myocyte Function With the Development of Congestive Heart Failure
Circulation, November 9, 1999; 100(19): 2003 - 2009.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. H. McElmurray III, R. Mukherjee, R. B. New, A. C. Sampson, M. K. King, J. W. Hendrick, A. Goldberg, T. J. Peterson, H. Hallak, M. R. Zile, et al.
Angiotensin-Converting Enzyme and Matrix Metalloproteinase Inhibition with Developing Heart Failure: Comparative Effects on Left Ventricular Function and Geometry
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 799 - 811.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
F. G. Spinale, M. L. Coker, S. R. Krombach, R. Mukherjee, H. Hallak, W. V. Houck, M. J. Clair, S. B. Kribbs, L. L. Johnson, J. T. Peterson, et al.
Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure : Effects on Left Ventricular Dimensions and Function
Circ. Res., August 20, 1999; 85(4): 364 - 376.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. D. Prabhu
Load sensitivity of left ventricular relaxation in normal and failing hearts: evidence of a nonlinear biphasic response
Cardiovasc Res, August 1, 1999; 43(2): 354 - 363.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. W Moe and P. Armstrong
Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure
Cardiovasc Res, June 1, 1999; 42(3): 591 - 599.
[Full Text] [PDF]


Home page
HeartHome page
J V De Giovanni, A Dindar, M J Griffith, R A Edgar, E D Silove, O Stumper, and J. C Wright
Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children
Heart, June 1, 1998; 79(6): 588 - 592.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Zile, M. K. Cowles, J. M. Buckley, K. Richardson, B. A. Cowles, C. F. Baicu, G. Cooper IV, and V. Gharpuray
Gel stretch method: a new method to measure constitutive properties of cardiac muscle cells
Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H2188 - H2202.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. V. Thomas, M. L. Coker, J. L. Zellner, J. R. Handy, A. J. Crumbley III, and F. G. Spinale
Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated Cardiomyopathy
Circulation, May 5, 1998; 97(17): 1708 - 1715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. L. Coker, C. V. Thomas, M. J. Clair, J. W. Hendrick, R. S. Krombach, Z. S. Galis, and F. G. Spinale
Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1516 - H1523.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. G. Spinale, M. L. Coker, C. V. Thomas, J. D. Walker, R. Mukherjee, and L. Hebbar
Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart Failure : Relation to Ventricular and Myocyte Function
Circ. Res., March 9, 1998; 82(4): 482 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. G. Spinale, H. H. Holzgrefe, R. Mukherjee, M. L. Webb, R. B. Hird, M. J. Cavallo, J. R. Powell, and W. H. Koster
Angiotensin-Converting Enzyme Inhibition and Angiotensin II Subtype-1 Receptor Blockade during the Progression of Left Ventricular Dysfunction: Differential Effects on Myocyte Contractile Processes
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1082 - 1094.
[Abstract] [Full Text]


Home page
CirculationHome page
F. G. Spinale, M. de Gasparo, S. Whitebread, L. Hebbar, M. J. Clair, D. M. Melton, R. S. Krombach, R. Mukherjee, J. P. Iannini, and S.-J. O
Modulation of the Renin-Angiotensin Pathway Through Enzyme Inhibition and Specific Receptor Blockade in Pacing-Induced Heart Failure : I. Effects on Left Ventricular Performance and Neurohormonal Systems
Circulation, October 7, 1997; 96(7): 2385 - 2396.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
R. P. Shannon, S. Friedrich, M. Mathier, and D. R. Knight
Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure
Cardiovasc Res, June 1, 1997; 34(3): 464 - 472.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Koide, M. Nagatsu, M. R. Zile, M. Hamawaki, M. M. Swindle, G. Keech, G. DeFreyte, H. Tagawa, G. Cooper IV, and B. A. Carabello
Premorbid Determinants of Left Ventricular Dysfunction in a Novel Model of Gradually Induced Pressure Overload in the Adult Canine
Circulation, March 18, 1997; 95(6): 1601 - 1610.
[Abstract] [Full Text]


Home page
CirculationHome page
G. A. Helmer, M. D. McKirnan, R. Shabetai, G. R. Boss, J. Ross, and H. K. Hammond
Regional Deficits of Myocardial Blood Flow and Function in Left Ventricular Pacing–Induced Heart Failure
Circulation, November 1, 1996; 94(9): 2260 - 2267.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Ishizaka, H. Asanoi, O. Wada, T. Kameyama, and H. Inoue
Loading Sequence Plays an Important Role in Enhanced Load Sensitivity of Left Ventricular Relaxation in Conscious Dogs With Tachycardia-Induced Cardiomyopathy
Circulation, December 15, 1995; 92(12): 3560 - 3567.
[Abstract] [Full Text]


Home page
CirculationHome page
F. G. Spinale, H. H. Holzgrefe, R. Mukherjee, R. B. Hird, J. D. Walker, A. Arnim-Barker, J. R. Powell, and W. H. Koster
Angiotensin-Converting Enzyme Inhibition and the Progression of Congestive Cardiomyopathy : Effects on Left Ventricular and Myocyte Structure and Function
Circulation, August 1, 1995; 92(3): 562 - 578.
[Abstract] [Full Text]